Cipla | CIPLA - Ebitda

Stock Price
1,323.50
Daily Change
-3.00 -0.23%
Monthly
0.80%
Yearly
-9.56%
Q1 Forecast
1,315.62

Cipla reported INR12.55B in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Arca Biopharma USD -25.07M 5.23M Mar/2025
aTyr Pharma USD -26.58M 26.32M Sep/2025
Bio Path USD -3.21M 631K Mar/2025
Brainstorm Cell Therapeutics USD -3.04M 99K Mar/2025
Capricor Therapeutics USD -24.58M 17.26M Mar/2025
Cara Therapeutics USD -2.39M 3.16M Mar/2025
Cipla INR 12.55B 6.4B Dec/2025
Dr.Reddys Laboratories INR 20.89B 117M Dec/2025
Esperion Therapeutics USD -27.51M 9.5M Sep/2023
Immunic USD -22.78M 753K Jun/2024
Infinity Pharmaceuticals USD -10.01M 1.39M Jun/2023
Minerva Neurosciences USD -4.36M 1.71M Sep/2024
Nektar Therapeutics USD -31.81M 70K Sep/2023
Sun Pharmaceuticals INR 49.48B 8.52B Dec/2025
TherapeuticsMD USD -1.64M 700K Sep/2023
UPL INR 23.17B 1.12B Dec/2025